Navigation Links
Arsenic May Have Been Responsible For The Madness Of King George III Of England

An interesting study from hair of King George III reveals that he may// have been consuming Arsenic and this lead to his unusually severe and prolonged bouts of madness.

Lancet has published this report this week and at last has been able to throw light on the reason for the madness of the famous English King George III. The study reports to have found high concentrations of arsenic in a sample of King George III’s hair and this may have been the main contributory factor.

Prof. Martin Warren and colleagues investigated exposure of arsenic in a sample of the King’s hair. Professor Warren said: “The presence of arsenic in a sample of the King’s hair provides a plausible explanation for the length and severity of his attacks of illness; and contamination of his antimonial medications is the probable source of the arsenic. We propose that exposure to arsenic would exacerbate attacks of porphyria in a genetically predisposed individual.

King George III was diagnosed to have suffered from Porphyria- a genetic defect leading to the faulty synthesis of a protein. However during his regime he suffered from five major episodes of prolonged and profound mental derangement. The King’s illness was originally thought to be a psychiatric disorder. However, there is little information available to account for the unusual persistence, severity, and late onset of attacks.

When the researchers looked at the Royal physician’s medical notes to try and identify the source of the arsenic; they found that the principal compound administered to the King during his illness was emetic tartar. Emetic tartar contains a substance called antimony, which can be contaminated with arsenic. The authors believe that the King’s medication was the source of the arsenic found in the hair sample.

News Extract - Newswise.
Original Source: Lncet
'"/>




Page: 1

Related medicine news :

1. Chickens Found To Have High Levels of Arsenic
2. Arsenic poisoning reactions can be traced to genes
3. Arsenic in drinking water
4. Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life
5. Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc
6. Arsenic Compound Effective in Treating Rare Leukemia
7. Arsenic in Chicken Feed may Cause Health Complications
8. PET Scan find the Area of Brain Responsible for Anorexia Nervosa
9. Gene That Might Be Responsible For Aging
10. Enzyme Responsible For Congenital Blindness
11. New Virus Held Responsible For Respiratory Infection In Children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... Providence, Rhode Island (PRWEB) , ... May 04, ... ... was launched in April 2016. SS&A teamed up with one of the top ... This legal information portal contains informative legal articles related to the law firm's ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of ... life forever with a same-day LASIK procedure at Christenbury Eye Center. The ... Jonathan Christenbury performed her surgery the same day as her in-office consultation and eye ...
(Date:5/4/2016)... ... May 04, 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which ... is hosting a free seminar on stem cell injections. The seminar is scheduled for ... Sport, 4601 Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... powerful cellular therapy software application that helps blood and marrow transplant (BMT) programs ... Transtem’s initial launch, Mediware has continued to enhance core application features. These enhancements ...
(Date:5/4/2016)... ... May 04, 2016 , ... International Conference on Obesity ... 25-27, 2016 at Las Vegas. It aims to bring together academicians, scientists, dietitians, ... research organizations across the globe; making the conference a perfect platform to share ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 Yissum ... announced today that it had signed an exclusive ... , developer of novel protein degradation and immunomodulatory drugs ... commercialization of drug candidates representing first-in-class therapy for hematologic ... not disclosed. The novel technology was developed ...
(Date:5/4/2016)... 2016 Valeritas Holdings, Inc. (OTCQB: ... public offering (APO). This was accomplished via a reverse ... and a private placement of approximately 5 million shares ... Under the terms of the reverse merger, ... Inc. will trade on the OTC Markets under the ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Ischemic Stroke ...  report to their offering.       ... Global Acute Ischemic Stroke Market and ... into Acute Ischemic Stroke pipeline products, Acute ...
Breaking Medicine Technology: